Suggestions

Du même auteur

Dismal outcome of refractory or relapsing patients with myelodysplasia‐related acute myeloid leukemia partially alleviated by intensive chemotherapy

Archive ouverte | Leroy, Harmony | CCSD

International audience. Abstract Background Acute myeloid leukemia (AML) with myelodysplasia‐related characteristics is a heterogeneous subset of AML that has been challenged throughout the history of myeloid malign...

Intermediate-dose cytarabine or standard-dose cytarabine plus single-dose anthracycline as post-remission therapy in older patients with acute myeloid leukemia: impact on health care resource consumption and outcomes

Archive ouverte | Galtier, Jean | CCSD

International audience. The treatment of older patients with newly diagnosed acute myeloid leukemia (AML) depends on their fitness. Fit patients receive an induction chemotherapy similar to that of younger patients ...

Delivering HDAC over 3 or 5 days as consolidation in AML impacts health care resource consumption but not outcome

Archive ouverte | Dumas, Pierre-Yves | CCSD

International audience. Postremission treatment is crucial to prevent relapse in acute myeloid leukemia (AML). High-dose cytarabine delivered every 12 hours on days 1, 3, and 5 (HDAC-135) is the standard of care for...

Chargement des enrichissements...